Prospective evaluation of a peripherally administered three‐in‐one parenteral nutrition product in dogs

Abstract

Using the product for 24 hours/day may require catheter replacement due to line failure. Other than line failure, which may be improved by 10- to 12-hour infusion times, this product was found to be safe and practical for short-term peripheral parenteral nutrition in dogs.

Retrospective evaluation of ProcalAmine administration in a population of hospitalized ICU dogs: 36 cases (2010–2013)

“…[25][26][27] Studies evaluating the use of PN solutions in clinical veterinary patients are limited; however, the most recent studies similarly concluded that the most common metabolic complication associated with PN was hyperglycemia. 3,17,[28][29][30] In the current study, 4 of 36 patients with normal glucose values prior to Pro-calAmine infusion developed hyperglycemia following administration of this PPN solution. The clinical significance of this finding is questionable, however, as these dogs exhibited mild hyperglycemia (< 9.9 mmol/L [180 mg/dL]) that did not prompt clinical intervention.…”

A commercial soy‐based phospholipid emulsion accelerates clot formation in normal canine whole blood and induces hemolysis in whole blood from normal and dogs with inflammatory leukograms

“…For example, 15% of neonatal foals given a lipid‐rich emulsion suffered a thrombotic complication in 1 study . In a study in dogs, the median time to severe mechanical complications or outright failure of the PN administration line due to thrombosis or apparent thrombophlebitis, inferred from clinical observations of swelling or redness of the leg, was 36 hours . In another study, mechanical complications occurred in 25% (81/319) dogs given PN.…”

Fluid Therapy and Nutritional Support

“…21 The goal with this form of PN is to supply a portion of the daily caloric requirements through a peripheral line without inducing thrombophlebitis secondary to excessive hypertonicity. Peripheral PN-as noted, also commonly abbreviated PPN-has been utilized (MacEntire D: Personal communication, 2009) and evaluated clinically in dogs.…”

“…Peripheral PN-as noted, also commonly abbreviated PPN-has been utilized (MacEntire D: Personal communication, 2009) and evaluated clinically in dogs. 21 This solution, which has higher osmolarity, caloric density (0.63 kcal/mL), and amino acid concentration than the "custom" solution described further on, was administered to dogs at 2 mL/kg/hour. Administration of such solutions has been shown to improve nitrogen balance.…”